Shares of Honasa Consumer surged as much as 8.2% to INR 478.20 on the BSE on 6 October 2026, after the Mamaearth parent issued a bullish outlook for the second quarter of FY27.
The company said it expects net sales to grow in the low thirties per cent year on year for the quarter — a pace that would comfortably outpace most of India's consumer-goods incumbents.
The growth story is increasingly a portfolio story. Younger brands The Derma Co and Aqualogica are expected to post growth in the mid-forties per cent, while flagship Mamaearth itself is projected to grow sales in the high teens. That mix — a maturing hero brand still growing strongly, flanked by faster-growing second-generation labels — is exactly what investors want to see from a house of brands.
The market capitalisation stood at around INR 15,368 crore, putting Honasa firmly in the large-cap D2C conversation and a long way from the listing-day scepticism it once faced.
The rally also matters as a sentiment read for the wider new-age consumer sector. Honasa is the bellwether listed proxy for India's D2C economy; a strong quarter from it lifts the mood — and arguably the valuation multiples — for every digital-first brand still private.
For founders in beauty and personal care, the lesson is in the portfolio playbook: Mamaearth's scale buys distribution and credibility, while newer, sharply-positioned brands capture the fastest-growing sub-segments. Building one brand gets you started; building a second and third is what moves the stock.
Why it matters for founders
Honasa's 8.2% jump on a low-thirties growth outlook shows public markets reward the house-of-brands model. D2C founders: plan your second and third brands early — The Derma Co and Aqualogica's mid-forties growth is what is doing the heavy lifting.